Navigation Links
NeoClone gets $750K for ovarian cancer detection

Madison, Wis. - Of all the forms of cancer, ovarian cancer is one of the most difficult to detect in its early stages. The federal government is providing incentives for companies to develop methods of early detection, and a Madison biotechnology company is one of the beneficiaries.



Source:wistechnology.com By WTN News 06/06/07


Page: 1

Related biology technology :

1. NeoClone and Marlin Tech secure $167K in Wisconsin Development Funds
2. Lucigen receives $750K grant to boost biofuel yields
3. Quintessence Biosciences advances cancer drug
4. Medical College receives $1.4M cancer grant
5. GE Healthcare partners with UNC on breast cancer imaging research
6. Lance Armstrong and the future of cancer care
7. Medical College part of $5M cancer study
8. Quintessence cancer treatment chosen for clinical studies
9. UW finds new path to anti-cancer agents
10. GenTel licenses next generation cancer research
11. GenTel to distribute cancer research tool
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/19/2016)... ... May 19, 2016 , ... KCAS Bioanalytical and Biomarker Services, ... Director, Large Molecule & Biomarker Bioanalysis. , Dr. Siddiqui has more than 15 ... for preclinical and clinical safety programs. “We’ve seen significant demand for, and we ...
(Date:5/18/2016)... 2016 The Biotech industry continues to ... that there are no opportunities ahead. Today, ActiveWallSt.com has on ... THLD ), Seattle Genetics Inc. (NASDAQ: SGEN ... Corp. (NASDAQ: OPHT ). Sign up now to ... http://www.activewallst.com/ Threshold Pharmaceuticals Inc.,s shares gained ...
(Date:5/17/2016)... -- Haselmeier announces the launch by Merck ... EMA, the European Medicines Agency. Originally launched in 2011 ... new pen version includes enhancements to further improve the ... patients during use. Its enhanced design has ... with a larger display window that improves the readability ...
(Date:5/17/2016)... BASEL, Switzerland , May 17, 2016 /PRNewswire/ ... sciences company located in Basel, Switzerland ... an investigational oral inhibitor of P38 mitogen-activated protein ... ) , Strekin will build the ... Pamapimod in indications in which MAP Kinases play ...
Breaking Biology Technology:
(Date:5/9/2016)... UAE, May 9, 2016 Elevay ... comes to expanding freedom for high net worth professionals ... in today,s globally connected world, there is still no ... could ever duplicate sealing your deal with a firm ... passports by taking advantage of citizenship via investment programs ...
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/19/2016)... The new GEZE SecuLogic access ... "all-in-one" system solution for all door components. It can ... door interface with integration authorization management system, and thus ... minimal dimensions of the access control and the optimum ... offer considerable freedom of design with regard to the ...
Breaking Biology News(10 mins):